Your browser doesn't support javascript.
loading
The functional role of Nudt2 in human triple negative breast cancer.
Abu-Rahmah, Rasha; Nechushtan, Hovav; Hidmi, Sanaa; Meirovitz, Amichay; Razin, Ehud; Peretz, Tamar.
Afiliação
  • Abu-Rahmah R; Department of Oncology, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
  • Nechushtan H; Department of Biochemistry and Molecular Biology, Institute for Medical Research Israel-Canada, the Hebrew University of Jerusalem, Jerusalem, Israel.
  • Hidmi S; Department of Oncology, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
  • Meirovitz A; Department of Biochemistry and Molecular Biology, Institute for Medical Research Israel-Canada, the Hebrew University of Jerusalem, Jerusalem, Israel.
  • Razin E; Department of Oncology, Soroka-Ben Gurion University Medical Center, Beer-Sheeva, Israel.
  • Peretz T; Department of Biochemistry and Molecular Biology, Institute for Medical Research Israel-Canada, the Hebrew University of Jerusalem, Jerusalem, Israel.
Front Oncol ; 14: 1364663, 2024.
Article em En | MEDLINE | ID: mdl-38715773
ABSTRACT
The main known function of Nudix hydrolase 2 (Nudt2) is to hydrolyze the secondary messenger diadenosine 5', 5'''-p1, p4-tetraphosphate (Ap4A). In this study we examined the role of Nudt2 in breast carcinoma through its expression in human invasive ductal carcinoma tissues, and its functions in human triple negative breast cancer (TNBC) cell lines. A significantly higher expression of Nudt2 was observed in human invasive ductal carcinoma tissues compared to that in normal breast tissue. Knockdown of Nudt2 in TNBC cell lines resulted in a significant reduction in cellular proliferation via the Ki67 marker, accompanied by G0/G1 phase cell cycle arrest, in the migration and invasion of these cells and in tumorigenicity and anchorage-independent growth. It can therefore be concluded that Nudt2 plays a significant role in promoting TNBC growth.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2024 Tipo de documento: Article